Ecallantide National NME Drug Monograph

Number of Patients (%) Headache 8 (8) 6 (7) Nausea 5 (5) 1 (1) Diarrhea 4 (4) 3 (4) Pyrexia 4 (4) 0 Injection site reaction 3 (3) 1 (1) Nasopharyngitis 3 (3) 0 For further details on the safety results as reported in the published clinical trials, refer to the Appendix. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download